5P HER2DX risk-score in HER2-positive (HER2+) breast cancer following neoadjuvant and adjuvant anti-HER2-based treatment: An updated survival analysis
Title:
5P HER2DX risk-score in HER2-positive (HER2+) breast cancer following neoadjuvant and adjuvant anti-HER2-based treatment: An updated survival analysis
Author:
Saez, O. Martinez Brasó-Maristany, F. Griguolo, G. Brunet, L. Pare Dieci, M.V. Cortés, J. Cussac, A. Llombart Villacampa, G. Marín-Aguilera, M. Rey, M. Goberna, G. Munoz, M. Vivancos, A. Gonzalez, P. Villagrasa Parker, J. Conte, P.F. Prat, A. Pascual, T. Guarneri, V.